Marjorie Bosche

631 total citations
7 papers, 306 citations indexed

About

Marjorie Bosche is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Marjorie Bosche has authored 7 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Virology and 3 papers in Infectious Diseases. Recurrent topics in Marjorie Bosche's work include HIV Research and Treatment (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and HIV/AIDS drug development and treatment (2 papers). Marjorie Bosche is often cited by papers focused on HIV Research and Treatment (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and HIV/AIDS drug development and treatment (2 papers). Marjorie Bosche collaborates with scholars based in United States. Marjorie Bosche's co-authors include Ven Natarajan, Richard T. Davey, H. Clifford Lane, Julia A. Metcalf, Robin Dewar, Richard A. Lempicki, Joseph A. Kovacs, Joseph W. Adelsberger, Randy Stevens and W. Gregory Alvord and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Infectious Diseases.

In The Last Decade

Marjorie Bosche

6 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marjorie Bosche United States 5 234 149 142 47 36 7 306
Johanna Repits Sweden 9 208 0.9× 113 0.8× 124 0.9× 53 1.1× 19 0.5× 11 268
Barbara N. Phenix Canada 7 289 1.2× 142 1.0× 167 1.2× 122 2.6× 75 2.1× 7 416
Anne-Sophie Liovat France 7 240 1.0× 213 1.4× 100 0.7× 80 1.7× 65 1.8× 7 342
António Pires United Kingdom 9 184 0.8× 147 1.0× 95 0.7× 79 1.7× 19 0.5× 15 278
Mohammed Alali Australia 5 394 1.7× 295 2.0× 199 1.4× 50 1.1× 58 1.6× 5 465
Daniëlle van Manen Netherlands 10 307 1.3× 190 1.3× 162 1.1× 94 2.0× 29 0.8× 16 423
F Boulerice Canada 10 285 1.2× 140 0.9× 179 1.3× 87 1.9× 14 0.4× 15 405
Ann Dauphin United States 7 227 1.0× 151 1.0× 100 0.7× 62 1.3× 11 0.3× 7 328
Anne Couëdel-Courteille France 12 169 0.7× 183 1.2× 85 0.6× 75 1.6× 26 0.7× 17 364
Anna Haas Switzerland 7 156 0.7× 188 1.3× 89 0.6× 75 1.6× 13 0.4× 7 325

Countries citing papers authored by Marjorie Bosche

Since Specialization
Citations

This map shows the geographic impact of Marjorie Bosche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjorie Bosche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjorie Bosche more than expected).

Fields of papers citing papers by Marjorie Bosche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjorie Bosche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjorie Bosche. The network helps show where Marjorie Bosche may publish in the future.

Co-authorship network of co-authors of Marjorie Bosche

This figure shows the co-authorship network connecting the top 25 collaborators of Marjorie Bosche. A scholar is included among the top collaborators of Marjorie Bosche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjorie Bosche. Marjorie Bosche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Imamichi, Hiromi, Ven Natarajan, Francesca Scrimieri, et al.. (2025). Widespread tissue distribution of transcriptionally active, clonally expanded HIV-1 proviruses despite suppressive antiretroviral therapy. Journal of Clinical Investigation. 135(12).
2.
Ishaq, Mohammad, Marjorie Bosche, Xin Zheng, et al.. (2011). LIM kinase 1 - dependent cofilin 1 pathway and actin dynamics mediate nuclear retinoid receptor function in T lymphocytes. BMC Molecular Biology. 12(1). 41–41. 25 indexed citations
3.
Read, Sarah W., Richard A. Lempicki, Michele Di Mascio, et al.. (2008). CD4 T Cell Survival after Intermittent Interleukin‐2 Therapy Is Predictive of an Increase in the CD4 T Cell Count of HIV‐Infected Patients. The Journal of Infectious Diseases. 198(6). 843–850. 16 indexed citations
4.
Imamichi, Hiromi, Keith A. Crandall, Ven Natarajan, et al.. (2001). Human Immunodeficiency Virus Type 1 Quasi Species That Rebound after Discontinuation of Highly Active Antiretroviral Therapy Are Similar to the Viral Quasi Species Present before Initiation of Therapy. The Journal of Infectious Diseases. 183(1). 36–50. 98 indexed citations
5.
Lempicki, Richard A., Joseph A. Kovacs, Michael Baseler, et al.. (2000). Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4 + and CD8 + T cell turnover in HIV-infected patients. Proceedings of the National Academy of Sciences. 97(25). 13778–13783. 158 indexed citations
6.
Nandi, J, Marjorie Bosche, & R Levine. (1996). Effects of a phorbol ester and isoquinoline sulfonamides on rabbit parietal cell function.. Journal of Pharmacology and Experimental Therapeutics. 279(1). 97–105. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026